“The compound SR-17018 is the initial biased agonist with the mu opioid receptor that does not cause tolerance with Continual use,” says Stahl, a senior personnel scientist from the Bohn lab. “This is the attractive aspect for opportunity use during the context of Long-term, severe pain.”“We show that these compounds bind to a distinct we